XML 65 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Apr. 02, 2022
Apr. 02, 2022
Mar. 02, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Common stock, shares outstanding       4,073,757   4,073,757   2,823,072
Stock issued during period shares new issues       $ 5,740,758   $ 5,740,758    
Warrant to purchase of shares of common stock       124,258 0 124,258 0  
Fair value of warrants issued price per share       $ 3.91   $ 3.91    
Amortization of deferred financing costs           $ 90,801 $ 51,869  
Private Placement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Debt issuance costs     $ 175,924          
Underwriting expense     307,867          
Amortization of deferred financing costs       $ 25,935 $ 25,935 51,869 $ 51,869  
Private placement offering     $ 440,000          
Private placement agent     8.00%          
Accredited Investors [Member] | 12% Subordinated Notes [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Number of stock issued during period, shares     80,000          
Number of shares sold     2,000          
Sale of stock price per share     $ 1,000          
Value of stock sold     $ 1,000          
Conversion of units, shares     40          
Conversion of units     $ 2,000,000          
Accredited Investors [Member] | Private Placement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Number of stock issued during period, shares     875,000          
Price per share     $ 4.00          
Number of shares sold     955,000          
Proceeds from private placement     $ 3,500,000          
Securities Purchase Agreement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Placement agent cash       254,160   254,160    
Underwriting expense           492,181    
Securities Purchase Agreement [Member] | Taglich Brothers Inc [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
[custom:ProceedsFromIssuanceOfPrivatePlacementPercentage]   8.00%            
Placement agent cash $ 696,420 $ 696,420            
Warrant to purchase of shares of common stock 124,258 124,258            
Class of warrant or right, exercise price of warrants or rights $ 4.62 $ 4.62            
Debt issuance costs $ 165,406 $ 165,406   $ 47,607   $ 47,607    
Fair value of warrants issued price per share       $ 3.91   $ 3.91    
Amortization of deferred financing costs           $ 38,931    
Securities Purchase Agreement [Member] | Taglich Brothers Inc [Member] | Minimum [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Class of warrant or right, exercise price of warrants or rights $ 3.30 $ 3.30            
Securities Purchase Agreement [Member] | Taglich Brothers Inc [Member] | Maximum [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Class of warrant or right, exercise price of warrants or rights $ 3.97 $ 3.97            
Securities Purchase Agreement [Member] | Private Placement [Member] | 12% Subordinated Notes [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Number of stock issued during period, shares   2,964,500            
Stock issued during period shares new issues   $ 8,705,256            
Securities Purchase Agreement [Member] | Accredited Investors [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Number of stock issued during period, shares 1,242,588              
Price per share $ 4.62 $ 4.62            
Stock issued during period shares new issues   $ 5,740,756            
2015 Equity Incentive Plan [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Common stock capital shares reserved for future issuance       497,330   497,330    
Exercise of Outstanding Warrants [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Common stock capital shares reserved for future issuance       255,958   255,958    
Warrant [Member] | Private Placement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrant to purchase of shares of common stock     95,500 95,500   95,500    
Class of warrant or right, exercise price of warrants or rights     $ 4.00 $ 4.00   $ 4.00    
Debt issuance costs     $ 135,291          
Fair value of warrants issued price per share     $ 3.90          
Underwriting expense     $ 236,761          
Warrants term     5 years          
Warrant exercisable date           Mar. 30, 2027    
Warrant One [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrant to purchase of shares of common stock       3,000   3,000    
Class of warrant or right, exercise price of warrants or rights       $ 15.00   $ 15.00    
Warrant maturity date       Mar. 30, 2027   Mar. 30, 2027    
Warrant Two [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrant to purchase of shares of common stock       17,200   17,200    
Class of warrant or right, exercise price of warrants or rights       $ 12.50   $ 12.50    
Warrants exercisable description           March 30, 2027    
Warrant Three [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrant to purchase of shares of common stock       16,000   16,000    
Class of warrant or right, exercise price of warrants or rights       $ 9.00   $ 9.00    
Warrants exercisable description           March 30, 2027    
Warrant Member One [Member] | Private Placement [Member]                
Accumulated Other Comprehensive Income (Loss) [Line Items]                
Warrant to purchase of shares of common stock       124,258   124,258    
Class of warrant or right, exercise price of warrants or rights       $ 4.62   $ 4.62    
Warrant exercisable date           Mar. 30, 2027